Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenous Levetiracetam as First-Line Anticonvulsive Treatment in Patients With Non-Convulsive Status Epilepticus (Keppra)
This study is currently recruiting participants.
Study NCT00603135   Information provided by University Hospital, Basel, Switzerland
First Received: November 13, 2007   Last Updated: January 26, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Status Epilepticus, Non-Convulsive
Additional conditions recognized in this trial
Status Epilepticus
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Epilepsy
Nervous System Diseases
Interventions listed in this trial
first-line i/v-levetiracetam
Additional drug interventions recognized in this trial
Etiracetam
More general drug interventions related to this trial
Anticonvulsants
Central Nervous System Agents
Nootropic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University Hospital, Basel, Switzerland
University Hospital, Basel, Switzerland, Dr. med. Stephan Rüegg, Neurology
Clinical Trial Unit, University Hospital Basel, Switzerland


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services